Baupost Group - FINCH THERAPEUTICS GROUP INC ownership

FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 48 filers reported holding FINCH THERAPEUTICS GROUP INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Baupost Group ownership history of FINCH THERAPEUTICS GROUP INC
ValueSharesWeighting
Q1 2023$793
+62.2%
2,019,008
+98.1%
0.01%
+75.0%
Q4 2022$489
-100.0%
1,019,008
-9.3%
0.01%
-75.0%
Q3 2022$1,876,000
-41.2%
1,123,1080.0%0.03%
-31.9%
Q2 2022$3,190,000
-43.5%
1,123,1080.0%0.05%
-23.0%
Q1 2022$5,649,000
-50.0%
1,123,108
-0.8%
0.06%
-45.0%
Q4 2021$11,289,000
-28.1%
1,132,253
-6.3%
0.11%
-22.9%
Q3 2021$15,706,000
-5.9%
1,208,1590.0%0.14%
+6.7%
Q2 2021$16,693,000
-11.5%
1,208,1590.0%0.14%
-10.0%
Q1 2021$18,870,0001,208,1590.15%
Other shareholders

There were no reported owners of FINCH THERAPEUTICS GROUP INC in Q2 2022.

NameSharesValueWeighting ↓
View complete list of FINCH THERAPEUTICS GROUP INC shareholders